Fresenius enters phosphate binder market with PhosLo buy
This article was originally published in Clinica
Executive Summary
Fresenius Medical Care, the Bad Homburg, Germany-based dialysis products maker, has moved into the pharmaceutical market with the acquisition of an oral calcium-based phosphate binder for end-stage renal disease patients that generates annual US sales of around $40m.